Switch to:
More From Other Websites
[$$] Don't Expect an Amgen Breakup Aug 26 2016
Analyzing Goldman Sachs’s Stock Picks with Growing Dividends Aug 26 2016
Coverage initiated on Amgen by Gabelli & Co Aug 26 2016
Mylan offers price plan to help patients but its programs are still short on details Aug 26 2016
ADXS: Multiple Progresses Have Been Made Aug 25 2016
Amgen's Shameful Silence Covers Up Reasons for FDA Drug Rejection Aug 25 2016
Short Sellers Increase Bets in Major Biotechs Aug 25 2016
Amgen Gets CRL for Secondary Hyperparathyroidism Drug Aug 25 2016
[$$] FDA Rejects Amgen Hormonal-Imbalance Treatment Aug 24 2016
Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted... Aug 24 2016
6:04 pm Amgen: FDA issued Complete Response Letter for its Parsabiv (Etelcalcetide) NDA; company... Aug 24 2016
Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted... Aug 24 2016
Top trades for the 2nd half: Lending Club, Amgen & more Aug 24 2016
What Are Analysts’ Recommendations for AbbVie in 2016? Aug 23 2016
Top trades for the 2nd half: CVS, SQ & more Aug 23 2016
[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions Aug 22 2016
New Data Add To Understanding Of Repatha® (Evolocumab) In Multiple Patient Populations Aug 22 2016
AMGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... Aug 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK